The postantibiotic effects (PAEs) of 16 antibiotics or antibiotic combinations currently used against Burkholderia (Pseudomonas) pseudomallei were determined. The ␤-lactams had zero PAEs, while the carbapenems and ciprofloxacin induced median PAEs of 1 and 5 h, respectively. These results emphasize the need to maintain antibiotic levels above inhibitory concentrations in blood throughout the dosing interval in cases of severe melioidosis.
biotics were used at 4ϫ MIC or at achievable blood levels if 4ϫ MIC was inappropriate clinically (i.e., for kanamycin).
Broth cultures were incubated at 37ЊC on a rotary shaker (100 rpm). Logarithmic-phase cultures were prepared by diluting an overnight broth culture 1:10 in fresh Mueller-Hinton broth and incubating samples for 2 h. This culture was further diluted 1:10 in the final medium to give a final inoculum of approximately 5 ϫ 10 7 CFU of B. pseudomallei per ml. Tests were performed in sterile 30-ml bottles containing 10 ml of prewarmed Mueller-Hinton broth and the required concentrations of antibiotic. Antibiotic-free cultures were included as growth controls. All broths were incubated for 2 h (except imipenem, which had only 1 h of exposure because of its rapid bactericidal activity [11] ). They were then diluted 1:1,000 (10 l into 10 ml) in fresh warm Mueller-Hinton broth and reincubated for a further 6 h, except for cultures with ciprofloxacin, which were incubated for 9 h. To check that the dilution factor was adequate to remove all antibiotic activity, the control tube was diluted 1:1,000 in duplicate and a 1:1,000 dilution of imipenem was added to one tube. This second control tube was processed in the same way as other tubes. Viable counts were performed to check the initial inoculum and then were repeated after the 1:1,000 dilution and hourly thereafter. Aliquots (100 l each) from serial 10-fold dilutions were spread onto whole agar plates with a rotary plater, and the plates were incubated overnight at 37ЊC. Bacterial counts were plotted against time on a semilogarithmic scale. Using the equation PAE ϭ T Ϫ C, where T is the time in hours for counts in the test suspensions to increase 10-fold after exposure and dilution and C is the time for the control to do likewise, we calculated the PAE of each antibiotic or combination tested for each bacterial strain. An apparent PAE of Յ20 min was considered insignificant and designated zero PAE.
The durations of the PAEs observed for the five strains are shown in Table 1 . There was no carryover of antibiotic activity after the 1:1,000 dilution of imipenem. As the carbapenems are the most active of all antibiotics against B. pseudomallei (11), it was assumed that significant carryover would not occur for the other drugs. The ␤-lactams ceftazidime, amoxicillin-clavulanic acid, and piperacillin had zero PAEs. Imipenem, meropenem, and biapenem exhibited wide ranges of PAEs (0.5 to 3.66 h) for four of the strains tested. However, strain 770 had no PAE with any of the carbapenems. Doxycycline showed a minimal PAE of only 0.5 h for three strains, while trimethoprim-sulfamethoxazole and kanamycin each had a minimal PAE for one strain only. Ciprofloxacin had the greatest PAE; for four strains it had a PAE of 4.5 to 5 h, and for the other strain the PAE was 2.5 h. Only chloramphenicol and ciprofloxacin had PAEs for all five strains of B. pseudomallei.
Of the antibiotic combinations tested, ciprofloxacin plus doxycycline gave the longest PAE, with that for one strain being Ͼ7 h. One strain showed no increase, and three strains demonstrated slight increases in PAE compared with that of ciprofloxacin alone. The combinations of ciprofloxacin plus ceftazidime and doxycycline plus trimethoprim-sulfamethoxazole showed no synergistic PAEs. The addition of doxycycline to chloramphenicol negated the PAE observed for chloramphenicol alone. The combination of ceftazidime and kanamycin showed no PAE.
PAEs are important, particularly when rapidly eliminated antibiotics are used against life-threatening infections with relatively resistant organisms such as B. pseudomallei. However, the two parenteral antimicrobial agents currently recommended for the treatment of severe melioidosis, amoxicillinclavulanic acid and ceftazidime (12, 13) , had no demonstrable PAEs for B. pseudomallei. There was also no PAE with the combination of ceftazidime and kanamycin, the latter of which is the only aminoglycoside with any activity against B. pseudomallei; this lack of PAE contrasts the synergistic PAE of amikacin and ceftazidime demonstrated for P. aeruginosa (7) . The results for the ␤-lactams with B. pseudomallei are in accordance with most other studies on gram-negative organisms, but they are at variance with the finding for 10 strains of B. cepacia of variable PAEs with piperacillin (0 to 5.9 h) and ceftazidime (0 to 2.6 h) (8) . Studies with P. aeruginosa and members of the family Enterobacteriaceae have demonstrated consistent PAEs for the carbapenems and the fluoroquinolones (5, 10). Our findings with B. pseudomallei show that considerable strain-to-strain variation occurs for the carbapenems, with one strain failing to demonstrate any PAE. Interestingly, this strain had the longest ciprofloxacin PAE (5 h).
Antibiotic combinations are used for the long-term oral therapy of melioidosis. Most studies have shown that the production of a synergistic PAE in an antibiotic combination is dependent upon the individual antibiotics' abilities to induce PAEs (5-7). On the basis of tests against P. aeruginosa, ciprofloxacin appears to be a consistent exception to this rule; in combination with imipenem, there is no enhancement of its PAE (5, 6) . In contrast, for three of the five B. pseudomallei strains tested, the combination of ciprofloxacin and doxycycline showed a substantial increase in PAE compared with that of ciprofloxacin alone, from 1 to 4.5 h. The other combinations either did not show any increased PAE (indifference) or appeared to be antagonistic.
The standard methods of determining PAEs have been criticized recently (9), particularly for antibiotics which induce spheroplast formation, i.e., the ␤-lactams. However, assuming that these methods do give reasonable estimates of the in vivo PAE, the results of this study emphasize the need to maintain ceftazidime and amoxicillin-clavulanic acid levels above the MIC in blood throughout the dosing interval in cases of severe melioidosis. This finding supports preliminary clinical data that imply that eight-hour dosing with amoxicillin-clavulanic acid is not as effective as four-hour dosing (12) . Whether ceftazidime, the current treatment of choice for severe melioidosis, should be given as conventional eight-hour boluses or by continuous intravenous infusion (so that ceftazidime concentrations in blood do not fall below the MIC) is the subject of current study. The addition of ciprofloxacin confers a significant PAE on ceftazidime, and fluoroquinolones have been used in the treatment of melioidosis, although preliminary clinical results have not been encouraging (10a). The carbapenem antibiotics have an excellent all-round profile of activity against B. pseudomallei, with the lowest MICs, the greatest bactericidal activity (11) , and significant PAEs for many strains; they may yet prove useful for the treatment of severe melioidosis.
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